Wall Street analysts, who acted as lead underwriters for BillionToOne's Nasdaq debut last month, began coverage of the diagnostics firm on Monday with broadly upbeat views, pointing to its advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback